Inspire Investing LLC Acquires Shares of 6,048 Globe Life Inc. $GL

Key Points

• Inspire Investing LLC has acquired a stake of 6,048 shares in Globe Life Inc. (NYSE:GL), valued at approximately $797,000, during the first quarter of the year.
• Insider transactions reveal that CFO Thomas Peter Kalmbach sold 28,952 shares, resulting in a 48.56% decrease in his ownership, which could raise concerns regarding internal confidence in the company's future.
• Analysts project a favorable outlook for Globe Life, with several upgrades, increasing price targets, and a consensus rating of "Moderate Buy."

Inspire Investing LLC acquired a new stake in Globe Life Inc. (NYSE:GL - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 6,048 shares of the company's stock, valued at approximately $797,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Invst LLC purchased a new position in Globe Life in the 1st quarter valued at $694,000. Strs Ohio purchased a new position in shares of Globe Life during the 1st quarter worth $2,124,000. Ellsworth Advisors LLC purchased a new position in shares of Globe Life during the 1st quarter worth $4,472,000. Acadian Asset Management LLC purchased a new position in shares of Globe Life during the 1st quarter worth $322,000. Finally, Geneos Wealth Management Inc. raised its holdings in shares of Globe Life by 3.1% during the 1st quarter. Geneos Wealth Management Inc. now owns 3,717 shares of the company's stock worth $490,000 after acquiring an additional 113 shares during the period. Hedge funds and other institutional investors own 81.61% of the company's stock.

Insider Transactions at Globe Life

In other Globe Life news, CFO Thomas Peter Kalmbach sold 28,952 shares of Globe Life stock in a transaction dated Tuesday, July 29th. The stock was sold at an average price of $140.97, for a total value of $4,081,363.44. Following the completion of the transaction, the chief financial officer directly owned 30,665 shares of the company's stock, valued at $4,322,845.05. The trade was a 48.56% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Michael Clay Majors sold 10,000 shares of Globe Life stock in a transaction dated Friday, August 1st. The shares were sold at an average price of $137.41, for a total value of $1,374,100.00. Following the completion of the transaction, the executive vice president directly owned 47,066 shares of the company's stock, valued at approximately $6,467,339.06. This represents a 17.52% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 84,722 shares of company stock valued at $11,733,793. 1.51% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. Keefe, Bruyette & Woods lifted their price target on Globe Life from $145.00 to $155.00 and gave the stock an "outperform" rating in a report on Monday, July 28th. Cfra Research upgraded Globe Life to a "moderate buy" rating in a report on Friday, July 25th. Wall Street Zen upgraded Globe Life from a "hold" rating to a "buy" rating in a report on Friday, May 16th. JPMorgan Chase & Co. lifted their price target on Globe Life from $145.00 to $160.00 and gave the stock an "overweight" rating in a report on Tuesday, July 8th. Finally, BMO Capital Markets reiterated a "market perform" rating and set a $149.00 price target (up previously from $114.00) on shares of Globe Life in a report on Wednesday, July 30th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $152.45.

Globe Life Stock Down 0.2%

Shares of GL opened at $142.25 on Friday. The firm has a market cap of $11.52 billion, a P/E ratio of 11.37 and a beta of 0.56. Globe Life Inc. has a 12-month low of $100.27 and a 12-month high of $144.00. The company's 50-day moving average price is $134.42 and its 200 day moving average price is $126.70. The company has a current ratio of 0.06, a quick ratio of 0.06 and a debt-to-equity ratio of 0.43.

Globe Life (NYSE:GL - Get Free Report) last issued its quarterly earnings data on Wednesday, July 23rd. The company reported $3.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.25 by $0.02. The firm had revenue of $1.48 billion for the quarter, compared to analyst estimates of $1.50 billion. Globe Life had a net margin of 18.11% and a return on equity of 21.24%. Globe Life's revenue was up 2.9% on a year-over-year basis. During the same period in the previous year, the firm earned $2.97 EPS. Globe Life has set its FY 2025 guidance at 14.250-14.650 EPS. On average, sell-side analysts forecast that Globe Life Inc. will post 13.87 earnings per share for the current year.

Globe Life Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, October 3rd will be given a $0.27 dividend. This represents a $1.08 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Friday, October 3rd. Globe Life's payout ratio is currently 8.63%.

Globe Life Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.